ABOUT
Mission
Indigo’s mission is to give diabetics the extra sense for health and empower them to live their life to the fullest.
Vision
Indigo answers the pressing need for accurate and affordable diabetes management by providing novel high-tech solutions for advanced biomarker sensing characterized by the best possible user experience and highest product quality.
Indigo is committed to improving the quality of life of millions of people living with diabetes through innovation.
Vision
Indigo answers the pressing need for accurate and affordable diabetes management by providing novel high-tech solutions for advanced biomarker sensing characterized by the best possible user experience and highest product quality.
Indigo is committed to improving the quality of life of millions of diabetes patients through innovation.
Management
Danaë Delbeke PhD
CEO, inventor and co-founder
“I am proud to pioneer at Indigo groundbreaking technology that will have a positive impact on the life of millions of diabetes patients.”
Danaë Delbeke, PhD, successfully founded 5 photonics companies during the past 10 years (Luceda, Caliopa, Com&Sens, Indigo, Sentea).
Danaë Delbeke received her Ph.D. degree in Applied Sciences from Ghent University (UGent), Belgium in 2002. She holds a dozen of issued patents and several patent applications.
Koenraad Van Schuylenbergh PhD
CTO and co-founder
Dr. Koenraad Van Schuylenbergh received his Ph.D. degree in Applied Sciences from KULeuven, Belgium in 1996.
Koenraad has 20 years of experience in research and development in medical implant design, telemetry, micro electro-mechanical structures (MEMS), analog and radio circuits, advanced packaging for medical implants and integrated circuits, and in business development and commercialization of advanced technologies. He (co-)authored 28 issued patents and several patent applications.
David Stocker, MD
Independent Director and Board Member
David Stocker, MD received his medical degree from Zürich University, Switzerland.
David Stocker has 20+ years of commercial, market access and medical expertise in life sciences, with a successful track-record in scaling up start-ups such as MiniMed, VNUS, ev3, NovoCure and PulmonX.
about the company
Indigo is a young high-tech medical device company creating a paradigm shift in the diabetes healthcare.
Indigo develops the next-gen needle-free glucose sensors for people living with diabetes. Our first product addresses the need for accurate glucose monitoring systems with a streamlined user experience. Indigo exploits groundbreaking photonics technology that revolutionized the Internet during the last decades and will now revolutionize diabetes management.
Indigo operates in stealth mode to focus on product development and accelerate market launch.
investors
The funding is provided by an international investment syndicate led by Thuja Capital Healthcare Fund II and PMV, and includes Sensinnovat, Parana Management Corp, Qbic Arkiv Fund, Fidimec, SOFI, Manuardeo and Capricorn ICT Arkiv as co-investors.